News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2024 Shelley Wood December 03, 2024
News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024
Presentation TCT 2024 TCT 999: ReliaSeal Trial: A Randomized Trial of Multiple Venous Access Closure With MYNX CONTROL™ VENOUS Vascular Closure Device and Manual Compression After Catheter-Based Ablation Procedures Presenter: Sanjaya Gupta October 30, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2024 Shelley Wood October 01, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2024 Shelley Wood April 03, 2024
Presentation THT Abstracts 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF Presenter: Sheldon Litwin March 04, 2024
Presentation THT Abstracts 2024 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis † Presenter: Marat Fudim March 04, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024